All News

RA Hands Difficult deformity

What Factors Predict RA in First-Degree Relatives?

MedPage Today

Among a cohort of first-degree relatives of patients with rheumatoid arthritis (RA), certain patient characteristics, as well as symptoms, helped predict a possible increased risk for developing the disease, U.K. researchers reported.

Read Article
RheumNow Podcast square

RheumNow Podcast – Booster Shots for COVID (8.13.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
knee.surgery.jpg (keep)

Biologics Reduce Surgical Needs in RA

Jack Cush, MD

In Canada, biologic DMARDs (bDMARDs) were introduced after 2001, and since that time there have been significant reductions in hip and knee arthroplasty (THA/TKA) among patients with rheumatoid arthritis (RA), but not in patients with osteoarthritis (OA).

Read Article
tea

More Tea, Less Rheumatoid

Jack Cush, MD

A large cohort study of rheumatoid arthritis (RA) patients shows that regular tea consumption was associated with a lower risk of RA.

Read Article
mtx.png (keep)

Safety and Tolerability of Subcutaneous Methotrexate

Jack Cush, MD

A large, single-rheumatology center analysis of oral and subcutaneous (SC) methotrexate (MTX) use in daily clinical practice suggests that SC MTX has fewer drug discontinuations and is better tolerated compared to other DMARD therapies.

Read Article
tkr_0.JPG

Delays in Joint Replacement as JIA Patients Reach Adulthood

Jack Cush, MD

A retrospective cohort study examined the need for joint replacement surgery in juvenile idiopathic arthritis (JIA) and showed there has been a trend to delay arthroplasty over time. The JIA category, year of implant, and presence of complications significantly affected implant survivorship.

Read Article
covid vaccine

Rheumatic Flares Uncommon After COVID Vax

MedPage Today

Post-vaccination disease flares were uncommon among patients with rheumatic and musculoskeletal diseases who were inoculated against COVID-19, researchers found.

Read Article
morbidity,covid,heart,lung,brain

Multimorbidity Impairs Responses in Rheumatoid Arthritis

Jack Cush, MD

A retrospective analysis of the ACR RISE registry shows that multimorbidity is not only common in patients with active rheumatoid arthritis (RA), but also impacts treatment choices and outcomes.

Read Article
kids,learn,book

Rheumatoid Arthritis Offspring Show Normal School Performance

Jack Cush, MD

A prospective, longitudinal study of the cognitive development of children born to mothers with rheumatoid arthritis (RA) demonstrates normal development as measured by comparative school test scores.

Read Article
Analysis of 7815 RA patients (female, 85%) w/ 340 H. Zoster events (309 pts). HZ rates were lower in men vs women 8.5 vs 11 HZ/1000 Pt-Yrs. Zoser Risk factors: incr HAQ (OR 1.51), MTX use (1.58), and biologic use (1.88) https://t.co/p0MTlwgJ8g Conclusions

Links:

Dr. John Cush RheumNow ( View Tweet)

Among a cohort of first-degree relatives of patients with rheumatoid arthritis (RA), certain patient characteristics, as well as symptoms, helped predict a possible increased risk for developing the disease, U.K. researchers reported. https://t.co/7geaJDO8O8 https://t.co/opIu4gXxin

Links:

Dr. John Cush RheumNow ( View Tweet)
Osteoarthritis vs. Rheumatoid Arthritis https://t.co/qvVEcKqNAM https://t.co/WDyIZxoL7v

Links:

Dr. John Cush RheumNow ( View Tweet)
A Top Tweet this Week: A large cohort study of rheumatoid arthritis (RA) patients shows that regular tea consumption was associated with a lower risk of RA. https://t.co/ODTs7PdGTN https://t.co/69mi8IlBdj

Links:

Dr. John Cush RheumNow ( View Tweet)
Symptom eval of 870 1st degree relatives of RA in PREVeNT-RA study - 5% were seropositive & 14% had incr CRP. Sleep probs (20%) & joint pain (18%) most common. Symmetrical small joint pain ~12% higher in RF+ and 11% higher w/ high CRP https://t.co/aYoLX0sZ2p

Links:

Dr. John Cush RheumNow ( View Tweet)

Pfizer has another JAK inhibitor - ritlecitinib - shown to be effective (vs PBO) in alopecia areata in the Phase 2b/3 ALLEGRO trial. Ritlecitinib is also being studied in vitiligo, rheumatoid arthritis, Crohn’s & ulcerative colitis. https://t.co/ccx0eRXuTS https://t.co/fApTP7WaYU

Links:

Dr. John Cush RheumNow ( View Tweet)
"Fibromyalgianess" is highlighted as a risk factor for undue, extended glucocorticoid use in rheumatoid arthritis (RA) patients, according to Wallace and colleagues in Rheumatology. https://t.co/uv19GSZsBV https://t.co/aSFlV9zeGt

Links:

Dr. John Cush RheumNow ( View Tweet)
Registry data suggests an increased risk of herpes zoster (HZ, shingles) in rheumatoid arthritis (RA) patients taking JAK inhibitors (JAKi) but also with other biologic DMARDs, compared to csDMARDs. https://t.co/Uu1VjAbKMi https://t.co/uGvTyLExjf

Links:

Dr. John Cush RheumNow ( View Tweet)
The ARTIS Study Group has published their analysis of (non-skin) cancer risk in rheumatoid arthritis, claiming the overall safety of biologic DMARDs and targeted synthetic DMARDs (tsDMARDs). https://t.co/RNWrLR53Wx https://t.co/mMmKKrX9vx

Links:

Dr. John Cush RheumNow ( View Tweet)
Worth another share-- Turning the Corner on CV Risk in Rheumatoid Arthritis by Richard Conway ( @RichardPAConway) #EULAR2021 https://t.co/S0ownscRKv https://t.co/7QtynRKAd6

Links:

Dr. John Cush RheumNow ( View Tweet)
Pain Persists in RA, Even Without Inflammation One-third of patients with rheumatoid arthritis had unacceptably high levels of pain 5 years after diagnosis, often despite low levels of inflammation, Swedish researchers found. https://t.co/K8zf1pE9jM https://t.co/aEBu7jVHft

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×